Skip to main content
Log in

Surgery + adjuvant therapy beneficial for cervical cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Jewell EL, Kulasingam S, Myers ER, Secord AA, Havrilesky LJ.Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. Gynecologic Oncology 107: 532-540, No. 3, Dec 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Surgery + adjuvant therapy beneficial for cervical cancer. Pharmacoecon. Outcomes News 546, 6 (2008). https://doi.org/10.2165/00151234-200805460-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805460-00015

Keywords

Navigation